跳至主要内容
临床试验/ACTRN12615000049572
ACTRN12615000049572已完成未知

Efficacy and safety of artesunate+sulfadoxine/ pyrimethamine and artemether+lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bosaso, Puntland, Somalia

Ministry of Health, Puntland, Somalia0 个研究点目标入组 176 人开始时间: 2015年1月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
176

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
6 Months 至 60 Years(—)
性别
All

入选标准

  • 1. age between 6 months and 60 years with the exception of 12-17 years old female minors and unmarried females above 18 years and above;
  • 2. mono-infection with P. falciparum detected by microscopy;
  • 3. parasitaemia of 500 - 200000 per microliter asexual forms;
  • 4. presence of axillary temperature greater or equal 37.5 degrees centigrade or history of fever during the past 24 h;
  • 5. ability to swallow oral medication;
  • 6. ability and willingness to comply with the study protocol for the duration of the study and to comply with the study visit schedule;
  • 7. informed consent from the patient or from a parent or guardian in the case of children aged less than 18 years;
  • 8. informed assent from any minor participant aged from 12 to age of majority years; and
  • 9. consent for pregnancy testing from married female of 18 years and above.

排除标准

  • 1. presence of general danger signs in children aged under 5 years or signs of severe falciparum malaria according to the definitions of WHO;
  • 2. weight under 5 kg;
  • 3. mixed or mono-infection with another Plasmodium species detected by microscopy;
  • 4. presence of severe malnutrition (defined as a child aged 6-60 months who has a mid-upper arm circumference < 115 mm;
  • 5. presence of febrile conditions due to diseases other than malaria (e.g. measles, acute lower respiratory tract infection, severe diarrhea with dehydration) or other known underlying chronic or severe diseases (e.g. cardiac, renal and hepatic diseases, HIV/AIDS);
  • 6. regular medication, which may interfere with antimalarial pharmacokinetics;
  • 7. history of hypersensitivity reactions or contraindications to any of the medicine(s) being tested or used as alternative treatment(s);
  • 8. a positive pregnancy test or breastfeeding of married women aged 18 years and above; and
  • 9. unable to or unwilling to take pregnancy test or to use contraception for women of child-bearing age and who are sexually active

研究者

发起方
Ministry of Health, Puntland, Somalia

相似试验

已完成
4 期
Efficacy and safety of artesunate+sulfadoxine/pyrimethamine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in At Tur Bani Qa'is, Harad, Almusaymir, Jabal Ash Sharq, Al Udayn and Bajil districts in YememalariaInfection - Studies of infection and infectious agentsPublic Health - Epidemiology
ACTRN12610000696099Ministry of Public Health and Population522
已完成
4 期
Efficacy and safety of artesunate+sulfadoxine/pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in Kassala (Kassala State), Kosti (White Nile state), Sinnar (Sinnar State), Damazin (Blue Nile State), SudaInfection - Studies of infection and infectious agentsMalaria
ACTRN12611001253998Federal Ministry of Health of Sudan352
已完成
4 期
Efficacy and safety of artesunate+sulfadoxine/pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in four sites of PakistaInfection - Studies of infection and infectious agentsMalaria
ACTRN12611001244998iaqat University of Medicine and Health Sciences340
已完成
4 期
Efficacy and safety of artesunate+ sulfadoxine/ pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in Jamame (Lower Jubba region), Janaale (Lower Shabelle region) and Jowhar (Middle Shabelle region), SomaliaInfection - Other infectious diseasesMalaria
ACTRN12611001009909Ministry of Health264
已完成
不适用
Efficacy and safety of artesunate and sulfadoxine-pyrimethamine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in low to moderate sentinel sites in SudaMalaria
ISRCTN45665690World Health Organization (WHO)/HIV/AIDS, Tuberculosis and Malaria (HTM) - Global Malaria Programme180